Standout Papers
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation (2011)
- Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial (2009)
- Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia (2001)
- Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism (2017)
- Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies (2013)
Immediate Impact
167 standout
Citing Papers
Aspirin or Low-Molecular-Weight Heparin for Thromboprophylaxis after a Fracture
2023 Standout
Diagnosis and Treatment of Acute Coronary Syndromes
2022 Standout
Works of Scott D. Berkowitz being referenced
Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease
2021
Rivaroxaban Plus Aspirin Versus Aspirin Alone in Patients With Prior Percutaneous Coronary Intervention (COMPASS-PCI)
2020
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Scott D. Berkowitz | 13285 | 8548 | 3252 | 193 | 16.5k | |
| Jack Ansell | 11332 | 7310 | 2397 | 222 | 15.9k | |
| Ajay K. Kakkar | 16334 | 19107 | 4530 | 187 | 23.1k | |
| Gary E. Raskob | 10851 | 12961 | 4697 | 168 | 19.1k | |
| Henri Bounameaux | 11071 | 16894 | 5414 | 220 | 20.3k | |
| Russell D. Hull | 8852 | 12963 | 5382 | 239 | 16.0k | |
| James D. Douketis | 7885 | 7663 | 3286 | 232 | 12.7k | |
| Giancarlo Agnelli | 8513 | 11461 | 3854 | 177 | 13.6k | |
| Grégoire Le Gal | 6294 | 10196 | 3100 | 408 | 13.5k | |
| Marc Rodger | 6821 | 10415 | 3333 | 268 | 15.1k | |
| Giancarlo Agnelli | 9001 | 11290 | 3338 | 329 | 15.8k |
All Works
Login with ORCID to disown or claim papers
Loading papers...